New diabetes drug candidate passes first safety check in healthy volunteers
NCT ID NCT05147259
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested the safety and how the body processes a new drug called HR011408 in 62 healthy adults. Participants received two different versions of the drug to compare them. The goal was to check for side effects and measure drug levels in the blood, not to treat diabetes. This is a first step before testing in people with diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HR011408 injection
- What this could lead to
- If successful, this could help develop a new treatment option for diabetes.
- What could go wrong
- This is an early Phase 1 trial in healthy people, not patients. It only tests safety and drug levels, not whether it works for diabetes. Many drugs fail in later stages.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES IN ADULTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shandong Provincial Qianfoshan Hospital
Jinan, Shandong, 250014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.